Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone

Minimum effective concentration of ropivacaine for 90% ultrasound-guided axillary brachial plexus block, with or without intravenous dexamethasone

•Minimum effective concentration for 90% of ropivacaine in axillary block is unknown.•Using 20 ml ropivacaine, we found a 4.4 mg/ml concentration.•Intravenous adjunct of 8 mg Dexamethasone does not allow to reduce it.•Dexamethasone increases sensory and motor block duration.•Dexamethasone improves p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical anesthesia 2021-12, Vol.75, p.110468-110468, Article 110468
Hauptverfasser: Grelet, Tommy, Besch, Guillaume, Puyraveau, Marc, Assila, Loubena, Pascual, Mathieu, Ferreira, David, Vettoretti, Lucie, Pili-Floury, Sébastien, Samain, Emmanuel, Berthier, Francis
Format: Artikel
Sprache:eng
Schlagworte:
Adjuvant
Amides
Analgesics
Anesthesia
Anesthetics, Local
Axillary block
Brachial plexus
Brachial Plexus Block - adverse effects
Dexamethasone
Diabetes
Humans
Intravenous dexamethasone
Minimum effective concentration
Pain
Patients
Regional anesthesia
Ropivacaine
Steroids
Success
Surgery
Ultrasonic imaging
Ultrasonography
Ultrasonography, Interventional
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Minimum effective concentration for 90% of ropivacaine in axillary block is unknown.•Using 20 ml ropivacaine, we found a 4.4 mg/ml concentration.•Intravenous adjunct of 8 mg Dexamethasone does not allow to reduce it.•Dexamethasone increases sensory and motor block duration.•Dexamethasone improves post-operative analgesia.
ISSN:0952-8180
1873-4529
DOI:10.1016/j.jclinane.2021.110468